BlossomHill Therapeutics, Inc.
BLSM
$16.18
-$0.17-1.04%
NASDAQ
| 03/31/2026 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 116.00M | 100.15M | |||
| Total Receivables | -- | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | 3.72M | -- | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -- | -- | |||
| Total Current Assets | 119.72M | -- | |||
|
|
|||||
| Total Current Assets | 119.72M | -- | |||
| Net Property, Plant & Equipment | 21.21M | -- | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | 2.48M | -- | |||
| Total Assets | 143.41M | -- | |||
|
|
|||||
| Total Accounts Payable | 5.38M | -- | |||
| Total Accrued Expenses | 10.31M | -- | |||
| Short-term Debt | -- | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | 493.00K | -- | |||
| Total Finance Division Other Current Liabilities | -- | -- | |||
| Total Other Current Liabilities | -- | -- | |||
| Total Current Liabilities | 16.18M | -- | |||
|
|
|||||
| Total Current Liabilities | 16.18M | -- | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | -- | -- | |||
| Capital Leases | 22.53M | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | -- | -- | |||
| Total Liabilities | 38.71M | -- | |||
|
|
|||||
| Common Stock & APIC | 3.92M | -- | |||
| Retained Earnings | -156.04M | -- | |||
| Treasury Stock & Other | -- | -- | |||
| Total Common Equity | -152.12M | -72.88M | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | 256.82M | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | 256.82M | 172.89M | |||
|
|
|||||
| Total Common Equity | -152.12M | -72.88M | |||
| Total Preferred Equity | 256.82M | 172.89M | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | 104.70M | 100.00M | |||
|
|
|||||